Inventor · Gurnee, IL, US

Cheol-Min Park

29Patents
15h-index
32Co-inventors
77Inventor score

Filing activity: Nov 30, 2000 → Dec 23, 2014

Most-cited inventions

PatentTitleAreaCited byStatus
US7390799B2 Apoptosis promoters Chemistry; Metallurgy 197 Active
US7767684B2 Apoptosis promoters Chemistry; Metallurgy 87 Active
US8563735B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 70 Active
US7642260B2 Apoptosis promoters Chemistry; Metallurgy 60 Active
US8586754B2 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 55 Active
US7973161B2 Apoptosis promoters Chemistry; Metallurgy 50 Active
US8173811B2 Apoptosis promoters Chemistry; Metallurgy 42 Active
US8084607B2 Apoptosis promoters Chemistry; Metallurgy 37 Active
US7709467B2 Apoptosis promoters Chemistry; Metallurgy 35 Active
US8614318B2 Apoptosis promoters Chemistry; Metallurgy 35 Active
US8354404B2 Apoptosis promoters Chemistry; Metallurgy 33 Active
US8343967B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 32 Active
US8952157B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 19 Active
US6624189B2 Byrostatin analogues, synthetic methods and uses Chemistry; Metallurgy 17 Expired
US8686136B2 Apoptosis promoters Chemistry; Metallurgy 17 Active
US7030115B2 N-sulfonylurea apoptosis promoters Chemistry; Metallurgy 13 Expired
US8338466B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Chemistry; Metallurgy 12 Active
US7256286B2 Bryostatin analogues, synthetic methods and uses Chemistry; Metallurgy 10 Expired
US7449485B2 N-sulfonylurea apoptosis promoters Chemistry; Metallurgy 10 Active
US7358251B2 N-sulfonylurea apoptosis promoters Chemistry; Metallurgy 10 Expired
US7585858B2 N-sulfonylcarboximidamide apoptosis promoters Chemistry; Metallurgy 10 Active
US9303025B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Emerging Cross-Sectional Technologies 9 Active
US9072748B2 BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 9 Active
US9125913B2 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Chemistry; Metallurgy 8 Active
US7906505B2 Apoptosis promoters Chemistry; Metallurgy 8 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.